Filter posts

Jim Greenwood: Biopharma Answers the Call for Cures

Recently, BIO President and CEO Jim Greenwood participated in a roundtable hosted by Congressman Joe …

Jack the Ripper Mystery May Be Solved through DNA Testing

Author Russell Edwards and Jari Louhelainen, a molecular biology professor at Liverpool John Moores University …

The Best Conspiracy Theories Never Die

The best conspiracy theories never die. They evolve and adapt. They rebuff troublesome facts, plug …

Patients Suffering from Gaucher's Disease Deserve Better

Gaucher Disease is one of the over 6,000 rare diseases that affect patients worldwide, representing …

BIO Participating in IDSA Stakeholder Group on Antimicrobial Resistance

BIO will be participating in a newly formed partnership which will work collaboratively to inform …

Tackling the Thorny Problem of Alzheimer’s

Football fans are gearing up for tonight’s opening game when the defending Champion Seattle Seahawks …

Pennsylvania Roundtable Answers the Call for Cures

Congressman Joe Pitts (PA-16) recently hosted a roundtable in Lancaster to discuss how to expedite …

The New Republic: We are Entering the Age of Alzheimer’s

The New Republic this week published a lengthy, powerful piece by Kent Russell on Alzheimer’s. …

Pitts Sounds off on Biosimilar Naming

This week, the Food and Drug Law Institute published a white paper – Biosimilar Nomenclature: …

4 Benefits of Plant-Made Pharmaceuticals

For centuries, plants have served as a natural source of treatments and therapies. New advances …